UroMems Receives Clearance from the FDA and the French ANSM for Initiating Landmark Pivotal Clinical Study of UroActive™ Smart Implant to Treat Male Stress Urinary Incontinence
GRENOBLE, France & MINNEAPOLIS, Minnesota (July 17, 2025) – UroMems, a global company developing innovative, mechatronics technology to treat stress urinary incontinence (SUI), received investigational device exemption (IDE) approval from…